DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Phase 2

Recruiting

Conditions: Metastatic Renal Cell Carcinoma
Oligoprogressive
Progression
Renal Cell Carcinoma

Interventions: Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2021-07-23

Last Posted Date: 2025-04-03

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT04974671

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Reducing Transphobia Among Adolescents Through a Brief Video Intervention

Not Applicable

Completed

Conditions: Transgenderism
Depression

Interventions: Behavioral: Short videos

First Posted Date: 2021-07-20

Last Posted Date: 2022-05-03

Lead Sponsor: Yale University

Target Recruit Count: 200

Registration Number: NCT04969003

Locations: 🇺🇸
Yale Child Center, New Haven, Connecticut, United States
🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors

Not Applicable

Active, not recruiting

Conditions: Cognition
Quality of Life
Depression

Interventions: Behavioral: Wait list control group
Behavioral: Digital neurotherapy (DNT) Treatment

First Posted Date: 2021-07-14

Last Posted Date: 2025-03-19

Lead Sponsor: Yale University

Target Recruit Count: 220

Registration Number: NCT04961047

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care

Not Applicable

Not yet recruiting

Conditions: Psychomotor Agitation
Behavioral Disorder

Interventions: Other: ED-TREAT

First Posted Date: 2021-07-13

Last Posted Date: 2025-04-06

Lead Sponsor: Yale University

Target Recruit Count: 26

Registration Number: NCT04959279

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes

Not Applicable

Completed

Conditions: Type1diabetes, Low Carbohydrate Diet

Interventions: Other: low carbohydrate diet
Other: standard carbohydrate diet

First Posted Date: 2021-07-09

Last Posted Date: 2025-04-25

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT04955691

Locations: 🇺🇸
Yale-New Haven Hospital, New Haven, Connecticut, United States

Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma

Phase 2

Active, not recruiting

Conditions: Metastatic Melanoma
Renal Cell Carcinoma
Lenvatinib
Melanoma
Brain Metastases
PD1/PD-L1 Experienced
Pembrolizumab

Interventions: Drug: Pembrolizumab
Drug: Lenvatinib

First Posted Date: 2021-07-09

Last Posted Date: 2025-04-11

Lead Sponsor: Yale University

Target Recruit Count: 56

Registration Number: NCT04955743

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Mindfulness Based Therapy for Insomnia in Black Women

Not Applicable

Completed

Conditions: Insomnia

Interventions: Behavioral: Mindfulness-based therapy for insomnia (MBTI)
Behavioral: Healthy lifestyle intervention

First Posted Date: 2021-07-06

Last Posted Date: 2023-11-07

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT04951466

Locations: 🇺🇸
Yale University - West Campus, Orange, Connecticut, United States

Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community

Not Applicable

Completed

Conditions: HIV Infections
Opioid-use Disorder
Tuberculosis
Hepatitis B
Depression
Syphilis
Hepatitis C

Interventions: Behavioral: SBIRT

First Posted Date: 2021-07-01

Last Posted Date: 2025-05-11

Lead Sponsor: Yale University

Target Recruit Count: 835

Registration Number: NCT04947475

Locations: 🇰🇬
AIDS Foundation East-West, Bishkek, Kyrgyzstan
🇲🇩
AFI - Act for Involvement, Chisinau, Moldova, Republic of
🇺🇦
Ukrainian Institute for Public Health Policy, Kyiv, Ukraine

Sympathetic Activation in Obesity

Not Applicable

Completed

Conditions: Obesity
Healthy

Interventions: Diagnostic Test: PET Scan
Dietary Supplement: Mixed Meal Test
Diagnostic Test: Muscle sympathetic nerve activity (MSNA)
Diagnostic Test: Oral Glucose Tolerance Test
Other: Body Composition, Percent Body Fat & Percent Body Water (Tanita scale)
Diagnostic Test: CT Scan
Other: Body Composition, Percent Body Fat & Percent Body Water (DXA Scan)

First Posted Date: 2021-07-01

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT04946552

Locations: 🇺🇸
Church Street Research Unit, New Haven, Connecticut, United States

Ketamine for the Treatment of Depression in Parkinson's Disease

Phase 2

Recruiting

Conditions: Parkinson's Disease
Depression

Interventions: Other: Placebo - Saline Infusion
Drug: Ketamine Infusion

First Posted Date: 2021-06-29

Last Posted Date: 2024-11-12

Lead Sponsor: Yale University

Target Recruit Count: 56

Registration Number: NCT04944017

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy